JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (NYSEARCA:BBMC – Get Free Report) saw strong trading volume on Monday . 74,196 shares traded hands during mid-day trading, an increase of 108% from the previous session’s volume of 35,594 shares.The stock last traded at $105.08 and had previously closed at $103.59.
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF Stock Performance
The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 16.22 and a beta of 1.15. The business’s 50 day moving average price is $96.76 and its 200 day moving average price is $92.04.
Institutional Trading of JPMorgan BetaBuilders U.S. Mid Cap Equity ETF
Several hedge funds and other institutional investors have recently added to or reduced their stakes in BBMC. Janney Montgomery Scott LLC increased its position in shares of JPMorgan BetaBuilders U.S. Mid Cap Equity ETF by 11.9% in the third quarter. Janney Montgomery Scott LLC now owns 140,109 shares of the company’s stock valued at $13,236,000 after buying an additional 14,899 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in JPMorgan BetaBuilders U.S. Mid Cap Equity ETF in the 3rd quarter worth $991,000. Finally, Sutton Place Investors LLC raised its position in JPMorgan BetaBuilders U.S. Mid Cap Equity ETF by 19.9% during the second quarter. Sutton Place Investors LLC now owns 2,755 shares of the company’s stock worth $242,000 after acquiring an additional 457 shares during the period.
About JPMorgan BetaBuilders U.S. Mid Cap Equity ETF
The JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) is an exchange-traded fund that mostly invests in mid cap equity. The fund tracks an index of US mid-cap equities, selected and weighted by market cap. BBMC was launched on Apr 14, 2020 and is managed by JPMorgan Chase.
Featured Articles
- Five stocks we like better than JPMorgan BetaBuilders U.S. Mid Cap Equity ETF
- Best Stocks Under $5.00
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Choose Top Rated Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for JPMorgan BetaBuilders U.S. Mid Cap Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan BetaBuilders U.S. Mid Cap Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.